Live wire
Wall Street's wire.
On your screen.
The same filings, ratings, and press releases hedge funds pay $24,000 a year to read - pushed to you the second they hit the wire. $59.99/month. No Terminal. No sales call.
Press wire · live
Streaming- PRGenerate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business UpdateGENB
- PRPrimo Brands Reports 2026 First Quarter ResultsPRMB
- PRHyperscale Data Executive Chairman Milton "Todd" Ault III to Speak at Consensus 2026 about Ault Blockchain and Tokenized CommoditiesGPUS
- PRGoldman Sachs, J.P. Morgan, TD Securities, Morgan Stanley, and Bank of America Join LTX in Bid to Unlock Greater Liquidity in Corporate BondsBR
- PRTuniu Has Regained Compliance with Nasdaq's Minimum Bid Price RequirementTOUR
- PRZKH Group Limited to Announce First Quarter 2026 Financial Results on Thursday, May 21, 2026ZKH
Bloomberg Terminal
$24,000per seat / year
Two monitors. A biometric keyboard. A department-level budget line item.
vs
Quantisnow
$59.99per month
Same wires. Same filings. Milliseconds, not minutes. Any browser. Cancel in two clicks.
We broke the $24,000 paywall.
Full pricing<200ms
Wire → screen
18+
Sources
12k+
Tickers covered
24/5
Market hours + after
The tape
Your broker sees it in ten minutes. You'll see it now.
- Chief Financial Officer Baruch Niran sold $32,039 worth of Ordinary Shares (3,750 units at $8.54) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 106,875 units (SEC Form 4)AUDC
- EVP and Chief Business Officer Aldema Lior sold $48,069 worth of Ordinary Shares (5,626 units at $8.54) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 115,314 units (SEC Form 4)AUDC
- New insider Tan Wen Yi claimed ownership of 650,600 shares (SEC Form 3)UMC
Top lists
The wire, ranked.
Market reports
Pre-market movers, midday and close summaries.
Trending now
Most-read on the wire in the last 24h.
Most-active companies
Tickers generating the most wire activity.
Latest insider purchases
Executives putting their own money in.
Analyst upgrades
Fresh rating and price-target moves.
FDA approvals
Approvals and regulatory decisions.
Trending (24h)
Most-read right now
- 1Galapagos Reports First Quarter 2026 Financial Results and Provides Business Update
- 2Hut 8 Reports First Quarter 2026 Results
- 3Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models
- 4Hut 8 Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- 5Hut 8 Commercializes First Phase of 1 GW Beacon Point AI Data Center Campus with 15-Year, 352 MW IT Lease with Base-Term Contract Value of $9.8 Billion
- 6Quantum Leap Energy Appoints Dr. Peter Fiske to Strategic Advisory Board
By market cap
Biggest companies we cover
Yesterday's news is expensive.
Two dollars a day buys you the same wire the pros use. Miss one edge and it's already paid for itself.